PUBLICATION: Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China
Pre-press Citation: Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020; doi: 10.1542/peds.2020-0702
Download a copy of this pre-publication version of the manuscript at the link below:
PUBLICATION: “Clinical strategies for treating pediatric cancer during the outbreak of 2019 novel coronavirus infection”
The following 1-page publication from Pediatric Blood & Cancer was recommended by one of your colleagues: https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28248
Paper of interest comparing cardiomyopathy risk following treatment with doxorubicin, daunorubicin or mitoxantrone.
The following paper was brought to our attention. As it does not have any Canadian authors it would not have been featured in your January Sosido Digests.
Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity.Feijen EAM, Leisenring WM, Stratton KL, Ness KK, van der Pal HJH, van Dalen EC, Armstrong GT, Aune GJ, Green DM, Hudson MM, Loonen J, Oeffinger KC, Robison LL, Yasui Y, Kremer LCM, Chow EJ.JAMA Oncol. 2019 Jan 31. doi: 10.1001/jamaoncol.2018.6634. [Epub ahead of print]